Pattern of Retained Contrast on Immediate Postprocedure Computed tomography (CT) After Particle Embolization of Liver Tumors Predicts Subsequent Treatment Response
Authors:
- Xiaodong WangXWXiaodong Wang
- Joseph P. ErinjeriJEJoseph P. Erinjeri
- Xiaoyu JiaXJXiaoyu Jia
- Mithat GonenMGMithat Gonen
- Karen T. BrownKBKaren T. Brown
- Constantinos T. SofocleousConstantinos T. Sofocleous
- George I. GetrajdmanGGGeorge I. Getrajdman
- Lynn A. BrodyLBLynn A. Brody
- Raymond H. ThorntonRTRaymond H. Thornton
- Majid MaybodyMMMajid Maybody
- Ann M. CoveyACAnn M. Covey
- Robert H. SiegelbaumRSRobert H. Siegelbaum
- 14 November 2012
- journal article
- research article
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 36 (4) , 1030-1038
Abstract
Purpose To determine if the pattern of retained contrast on immediate postprocedure computed tomography (CT) after particle embolization of hepatic tumors predicts modified Response Evaluation Criteria in Solid Tumors (mRECIST) response. Materials and Methods This study was approved by the Institutional Review Board with a waiver of authorization. One hundred four liver tumors were embolized with spherical embolic agents (Embospheres, Bead Block, LC Bead) and polyvinyl alcohol. Noncontrast CT was performed immediately after embolization to assess contrast retention in the targeted tumors, and treatment response was assessed by mRECIST criteria on follow-up CT (average time 9.0 ± 7.7 weeks after embolization). Tumor contrast retention (TCR) was determined based on change in Hounsfield units (HUs) of the index tumors between the preprocedure and immediate postprocedure scans; vascular contrast retention (VCR) was rated; and defects in contrast retention (DCR) were also documented. The morphology of residual enhancing tumor on follow-up CT was described as partial, circumferential, or total. Association between TCR variables and tumor response were assessed using multivariate logistic regression. Results Of 104 hepatic tumors, 51 (49 %) tumors had complete response (CR) by mRECIST criteria; 23 (22.1 %) had partial response (PR); 21 (20.2 %) had stable disease (SD); and 9 (8.7 %) had progressive disease (PD). By multivariate analysis, TCR, VCR, and tumor size are independent predictors of CR (p = 0.02, 0.05, and 0.005 respectively). In 75 tumors, DCR was found to be an independent predictor of failure to achieve complete response (p < 0.0001) by imaging criteria. Conclusion TCR, VCR, and DCR on immediate posttreatment CT are independent predictors of CR by mRECIST criteria.Keywords
This publication has 25 references indexed in Scilit:
- Transcatheter Treatment of Hepatocellular Carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): Technical RecommendationsCardioVascular and Interventional Radiology, 2011
- Safety Profile of Sequential Transcatheter Chemoembolization with DC Bead™: Results of 237 Hepatocellular Carcinoma (HCC) PatientsCardioVascular and Interventional Radiology, 2010
- Nonresectable Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Analysis of the Response and Prognostic Factors after Transcatheter Arterial ChemoembolizationRadiology, 2010
- Transarterial Liver-Directed Therapies of Neuroendocrine Hepatic MetastasesSeminars in Oncology, 2010
- Chemoembolization for Primary and Metastatic Liver CancerThe Cancer Journal, 2010
- Bland Embolization in Patients with Unresectable Hepatocellular Carcinoma Using Precise, Tightly Size-Calibrated, Anti-Inflammatory Microparticles: First Clinical Experience and One-Year Follow-UpCardioVascular and Interventional Radiology, 2009
- Transcatheter Arterial Embolization with Only Particles for the Treatment of Unresectable Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2008
- Particle embolization of recurrent hepatocellular carcinoma after hepatectomyCancer, 2006
- TREATMENT OF CARCINOID LIVER METASTASES BY HEPATIC-ARTERY EMBOLISATIONThe Lancet, 1977
- Therapeutic Transcatheter Arterial EmbolizationRadiology, 1974